Therapeutic Focus Areas

  • Alpha-1 Antitrypsin Deficiency

    Alpha-1 Antitrypsin Deficiency

    Committed to Alpha-1 Patients

    Alpha-1 antitrypsin deficiency (AATD) is the most common hereditary disorder in adults. It is associated with an increased risk of developing pulmonary emphysema and liver disease, and also skin problems (panniculitis) and vasculitis.

  • CMV Disease

    CMV Disease

    Supporting prevention of CMV disease after solid organ transplantation

    Cytomegalovirus (CMV) is a common virus for people of all ages. It belongs to the Herpesviridae family and is highly evolved and adapted to humans.

  • COVID-19


    Taking part in the fight against COVID-19

    Over the past months, our lives have changed dramatically as a result of the Coronavirus (COVID-19) pandemic. COVID-19 is caused by the novel virus SARS-CoV-2. As new facts about the virus and the pandemic are revealed, the international scientific community, along with the pharmaceutical industry, are making tremendous efforts in order to combat the disease. […]

  • Hepatitis B recurrence after liver transplantation

    Hepatitis B recurrence after liver transplantation

    Hepatitis B is a liver infection caused by the hepatitis B virus. It is a major global health problem. Some people with hepatitis B are sick for only a few weeks (known as an “acute” infection). Some people, especially those who get infected in adulthood, can clear the virus from their bodies without treatment. Hepatitis […]

  • Rabies


    Helping to prevent one of the deadliest diseases in the world

    Rabies is a preventable infectious viral disease that is almost always fatal following the onset of clinical symptoms. In up to 99% of cases, domestic dogs are responsible for rabies virus transmission to humans. Yet, rabies can affect both domestic and wild animals. It is spread to people through bites or scratches, usually via saliva. […]